indiansfan407 Posted - 6 hours ago

$CLRB how much cash do they have? when will they need to do a raise?

godly1 Posted - 7 hours ago

$CLRB 3 to 16 just like John 3:16

EddieH2020 Posted - 9 hours ago

$CLRB Well I was dumb to rebuy in at $3.85 lol should have known sub $3.40 was on deck

chiki007 Posted - 10 hours ago

$CLRB continue to buy while it’s cheap! market cap around 105M $. Cash around 55-60M $

Dingo2 Posted - 14 hours ago

$CLRB hmmm - getting shorted?

magoo007 Posted - 1 day ago

$CLRB err 11300 shares….

magoo007 Posted - 1 day ago

$CLRB now have over 12k shares… I’ll keep buying in this range all month.

Plutus Posted - 1 day ago

$CLRB This dude doesn't go big unless he's really feeling confident...

dcajic2 Posted - 1 day ago

$CLRB Months away from Being possibly bullish. They moved their filing of their NDA until July from March. They can’t go higher until they file. Just a short

Plutus Posted - 3 days ago

$CLRB Well, this recent trend is less than optimal. Tues news drop for a bump... maybe?

CLRBtothemoon Posted - 3 days ago

$CLRB loaded up again and back to 4$.

EddieH2020 Posted - 4 days ago

$CLRB

jacksparo Posted - 6 days ago

$SAVA $OCGN $ICU $CLRB Who remembers This legendary call ✅📈✅! My team few stocks in 2024 might do this move The MAGIC MICRO CAP APRIL EDITION 2024 is coming soon 🚀🚀🚀

ChicagoBull0780 Posted - 1 week ago

$CLRB i'm swinging right here.. entry 3.48 yesterday. Looking for .70-.80 cents per hopefully by tmrw..

JTSawyer66 Posted - 1 week ago

$CLRB

Plutus Posted - 1 week ago

$CLRB Buys over the past couple days - in it to win it:

szcyxzh Posted - 1 week ago

$CLRB fundamental matters. Show or die.

higgggghhhher Posted - 1 week ago

$CLRB I’ve gotten my ass handed to me every time playing the inflation game. Biden is mad at corporations for making record profits and still over charging..Corporations do not give one shit about us. They will not give a shit about is when AI is taking over the jobs as well. Crazy times

Plutus Posted - 1 week ago

$CLRB Well, I guess I should have waited longer to buy more...

higgggghhhher Posted - 1 week ago

$CLRB https://www.onclive.com/view/dr-nooka-on-the-utility-of-iopofosine-i-131-in-waldenstr-m-macroglobulinemia

EvenBetter99 Posted - 1 week ago

$CLRB The market only for WaM for Cellectar's new PDC cancer drug will possible be a multi Billion one. Even third line will boost their share price about 10x.

Glopolon Posted - 1 week ago

$CLRB Also need to consider the dosing requirements for CLR-131, only 2 doses per patient week 1 and then 2 weeks later another 2 doses.. Then a span of several months and repeat, and then done. That should not strain supply chains

higgggghhhher Posted - 1 week ago

$CLRB bmy didn’t buy fusion for their BS phase 2 product. They will use their manufacture plant to pump out indications

higgggghhhher Posted - 1 week ago

$CLRB Shane Lea, Matt Hagen, and Eric sure as hell did not leave BMY to roll the dice with a $100 million start up in the pursuit of helping the underdog. They are all in sales, they see big time commission checks and as an easy sale. They are late in their career, they aren’t looking for “that challenge” they are looking to make that money to retire

higgggghhhher Posted - 1 week ago

$CLRB Caruso has a 12in manadango that he can slap on the table at any time…we have multiple indications that will receive breakthrough designation/ accelerated approval. The data already show that it will…

higgggghhhher Posted - 1 week ago

$CLRB it’s a generational medical advancement in radiopharma and cancer treatment. It has shown to be effective in 80 different indications. It is durable and safe responses and it’s a 4 dose treatment and your done. It’s a big pharma cash cow and the abilities of the mechanism have not even nearly been tapped. We all know this the share price will change. Trust the data. Trust your DD

EddieH2020 Posted - 1 week ago

$CLRB 🤔

MrTraderJoe Posted - 1 week ago

$CLRB 🔥

Glopolon Posted - 1 week ago

$CLRB Covid-19 created a delay in enrollment for the trial = slow speed of execution

Glopolon Posted - 1 week ago

$CLRB Outsourcing production and manufacturing is not uncommon.. https://www.pharmtech.com/view/growing-opportunities-in-outsourced-biopharma-apis The patient population size should not put a strain on supply of CLR-131..